Benzinga's Top #PreMarket Losers

By: via Benzinga
EDAP TMS SA (NASDAQ: EDAP) fell 39.47% to $2.07 in pre-market trading following the FDA Panel rejection of Ablatherm-HIFU for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.